Intra-tumor heterogeneity: Lessons from microbial evolution and clinical implications

Genome Medicine

Volumn 5, Issue 11, 2013, Pages

  de Bruin, Elza C ^a   Taylor, Tiffany B ^b   Swanton, Charles ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BREAST CANCER; CELL INTERACTION; CHROMOSOMAL INSTABILITY; CHRONIC LYMPHATIC LEUKEMIA; DNA SEQUENCE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOMIC INSTABILITY; HUMAN; INTRATUMOR HETEROGENEITY; LUNG CANCER; METASTASIS POTENTIAL; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; MULTIDRUG RESISTANCE; MUTATION RATE; NONHUMAN; ONCOLOGICAL PARAMETERS; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SOMATIC MUTATION; THERAPY RESISTANCE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84888087317     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm505     Document Type: Review

References (88)

1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976, 194:23-28. 10.1126/science.959840, 959840.
2. Polyak K. Is breast tumor progression really linear?. Clin Cancer Res 2008, 14:339-341. 10.1158/1078-0432.CCR-07-2188, 18223205.
3. Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet 2012, 13:795-806. 10.1038/nrg3317, 3666082, 23044827.
4. Horswell S, Matthews N, Swanton C. Cancer heterogeneity and " The Struggle for Existence": Diagnostic and analytical challenges. Cancer Lett 2012,
5. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012, 72:4875-4882. 10.1158/0008-5472.CAN-12-2217, 3712191, 23002210.
6. Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013, 501:338-345. 10.1038/nature12625, 24048066.
7. Gerlinger M, Swanton C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer 2010, 103:1139-1143. 10.1038/sj.bjc.6605912, 2967073, 20877357.
8. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013, 501:346-354. 10.1038/nature12626, 24048067.
9. Murugaesu N, Chew SK, Swanton C. Adapting clinical paradigms to the challenges of cancer clonal evolution. Am J Pathol 2013, 182:1962-1971. 10.1016/j.ajpath.2013.02.026, 23708210.
10. Gorunova L, Hoglund M, Andren-Sandberg A, Dawiskiba S, Jin Y, Mitelman F, Johansson B. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 1998, 23:81-99. 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0, 9739011.
11. Teixeira MR, Heim S. Cytogenetic analysis of tumor clonality. Adv Cancer Res 2011, 112:127-149.
12. Teixeira MR, Pandis N, Bardi G, Andersen JA, Heim S. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res 1996, 56:855-859.
13. Navin NE, Hicks J. Tracing the tumor lineage. Mol Oncol 2010, 4:267-283. 10.1016/j.molonc.2010.04.010, 2904844, 20537601.
14. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117. 10.1038/nature09515, 3148940, 20981102.
15. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892. 10.1056/NEJMoa1113205, 22397650.
16. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J, Wigler M. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94. 10.1038/nature09807, 21399628.
17. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, Chen K, Walker J, McDonald S, Bose R, Ornitz D, Xiong D, You M, Dooling DJ, Watson M, Mardis ER, Wilson RK. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012, 150:1121-1134. 10.1016/j.cell.2012.08.024, 3656590, 22980976.
18. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, Heravi-Moussavi A, Rosner J, Lai D, Birol I, Varhol R, Tam A, Dhalla N, Zeng T, Ma K, Chan SK, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 2012, 486:395-399.
19. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149:979-993. 10.1016/j.cell.2012.04.024, 3414841, 22608084.
20. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M, Shlien A, Cooke SL, Hinton J, Menzies A, Stebbings LA, Leroy C, Jia M, Rance R, Mudie LJ, Gamble SJ, Stephens PJ, McLaren S, Tarpey PS, Papaemmanuil E, Davies HR, Varela I, McBride DJ, Bignell GR, Leung K, Butler AP, et al. The life history of 21 breast cancers. Cell 2012, 149:994-1007. 10.1016/j.cell.2012.04.023, 3428864,3428864, 22608083.
21. Maharjan RP, Ferenci T, Reeves PR, Li Y, Liu B, Wang L. The multiplicity of divergence mechanisms in a single evolving population. Genome Biol 2012, 13:R41. 10.1186/gb-2012-13-6-r41, 3446313, 22682524.
22. Kassen R. The experimental evolution of specialists, generalists, and the maintenance of diversity. J Evol Biol 2002, 15:173-190.
23. Chao L, Cox EC. Competition between high and low mutating strains of Escherichia coli. Evolution 1983, 37:125-134.
24. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001, 61:3230-3239.
25. Sprouffske K, Merlo LM, Gerrish PJ, Maley CC, Sniegowski PD. Cancer in light of experimental evolution. Curr Biol 2012, 22:R762-R771. 10.1016/j.cub.2012.06.065, 3457634, 22975007.
26. Calvo F, Sahai E. Cell communication networks in cancer invasion. Curr Opin Cell Biol 2011, 23:621-629. 10.1016/j.ceb.2011.04.010, 21570276.
27. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 2012, 196:395-406. 10.1083/jcb.201102147, 3283993, 22351925.
28. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51. 10.1016/j.cell.2010.03.014, 20371344.
29. Lambert G, Estevez-Salmeron L, Oh S, Liao D, Emerson BM, Tlsty TD, Austin RH. An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer 2011, 11:375-382. 3488437, 21508974.
30. Pikor L, Thu K, Vucic E, Lam W. The detection and implication of genome instability in cancer. Cancer Metastasis Rev 2013, doi: 0.1007/s10555-013-9429-5.
31. Schluter D. Experimental evidence that competition promotes divergence in adaptive radiation. Science 1994, 266:798-801. 10.1126/science.266.5186.798, 17730400.
32. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012, 487:500-504. 10.1038/nature11183, 3711467, 22763439.
33. Kerr B, Riley MA, Feldman MW, Bohannan BJ. Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature 2002, 418:171-174. 10.1038/nature00823, 12110887.
34. Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol 2013, 15:338-344. 10.1038/ncb2717, 23548926.
35. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Rev Cancer 2008, 8:755-768.
36. Ronce O, Kirkpatrick M. When sources become sinks: migrational meltdown in heterogeneous habitats. Evolution 2001, 55:1520-1531.
37. Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, Morsberger LA, Latimer C, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal SA, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Griffin CA, Burton J, Swerdlow H, Quail MA, Stratton MR, Iacobuzio-Donahue C, Futreal PA. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113. 10.1038/nature09460, 3137369,3137369, 20981101.
38. Rainey PB, Travisano M. Adaptive radiation in a heterogeneous environment. Nature 1998, 394:69-72. 10.1038/27900, 9665128.
39. Vaupel P, Hockel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. Int J Oncol 2000, 17:869-879.
40. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989, 49:6449-6465.
41. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461. 10.1126/science.1171362, 2998180, 19460966.
42. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013, 152:714-726. 10.1016/j.cell.2013.01.019, 23415222.
43. Descamps-Julien B, Gonzalez A. Stable coexistence in a fluctuating environment: an experimental demonstration. Ecology 2005, 86:2815-2824.
44. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510. 10.1038/nature10738, 3267864, 22237025.
45. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L, Walker NM, Stewart FM. The population genetics of antibiotic resistance. Clin Infect Dis 1997, 24:S9-S16. 10.1093/clinids/24.Supplement_1.S9, 8994776.
46. Wright S. The roles of mutation, inbreeding, crossbreeding and selection in evolution. Proc Sixth Int Congress Genet 1932, 1:356-366.
47. Wright S. Evolution and the Genetics of Populations, Volume 3 1977, Chicago: University of Chicage Press.
48. Lenski RE, Travisano M. Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations. Proc Natl Acad Sci U S A 1994, 91:6808-6814. 10.1073/pnas.91.15.6808, 44287, 8041701.
49. Zeyl C, Mizesko M, de Visser JA. Mutational meltdown in laboratory yeast populations. Evolution 2001, 55:909-917. 10.1554/0014-3820(2001)055[0909:MMILYP]2.0.CO;2, 11430651.
50. Buckling A, Kassen R, Bell G, Rainey PB. Disturbance and diversity in experimental microcosms. Nature 2000, 408:961-964. 10.1038/35050080, 11140680.
51. Massey RC, Buckling A. Environmental regulation of mutation rates at specific sites. Trends Microbiol 2002, 10:580-584. 10.1016/S0966-842X(02)02475-7, 12564995.
52. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol 2003, 6:452-456. 10.1016/j.mib.2003.09.001, 14572536.
53. Lynch M, Burger R, Butcher D, Gabriel W. The mutational meltdown in asexual populations. J Hered 1993, 84:339-344.
54. Soll SJ, Diaz Arenas C, Lehman N. Accumulation of deleterious mutations in small abiotic populations of RNA. Genetics 2007, 175:267-275. 1774997, 17110480.
55. Desai MM, Fisher DS. Beneficial mutation selection balance and the effect of linkage on positive selection. Genetics 2007, 176:1759-1798. 10.1534/genetics.106.067678, 1931526, 17483432.
56. Gerrish PJ, Lenski RE. The fate of competing beneficial mutations in an asexual population. Genetica 1998, 102-103:127-144.
57. Gudelj I, Weitz JS, Ferenci T, Claire Horner-Devine M, Marx CJ, Meyer JR, Forde SE. An integrative approach to understanding microbial diversity: from intracellular mechanisms to community structure. Ecol Lett 2010, 13:1073-1084. 10.1111/j.1461-0248.2010.01507.x, 3069490, 20576029.
58. Loewe L, Hill WG. The population genetics of mutations: good, bad and indifferent. Philos Trans R Soc Lond B Biol Sci 2010, 365:1153-1167. 10.1098/rstb.2009.0317, 2871823, 20308090.
59. Bailey SF, Dettman JR, Rainey PB, Kassen R. Competition both drives and impedes diversification in a model adaptive radiation. Proc Biol Sci 2013, 280:20131253. 10.1098/rspb.2013.1253, 23843392.
60. Harcombe W. Novel cooperation experimentally evolved between species. Evolution 2010, 64:2166-2172.
61. Nadell CD, Foster KR, Xavier JB. Emergence of spatial structure in cell groups and the evolution of cooperation. PLoS Comp Biol 2010, 6:e1000716.
62. Verbruggen E, El Mouden C, Jansa J, Akkermans G, Bucking H, West SA, Kiers ET. Spatial structure and interspecific cooperation: theory and an empirical test using the mycorrhizal mutualism. Am Nat 2012, 179:E133-E146. 10.1086/665032, 22504548.
63. Spiers AJ, Buckling A, Rainey PB. The causes of Pseudomonas diversity. Microbiology 2000, 146:2345-2350.
64. Herron MD, Doebeli M. Parallel evolutionary dynamics of adaptive diversification in Escherichia coli. PLoS Biol 2013, 11:e1001490. 10.1371/journal.pbio.1001490, 3576414, 23431270.
65. Koza A, Moshynets O, Otten W, Spiers AJ. Environmental modification and niche construction: developing O2 gradients drive the evolution of the Wrinkly Spreader. ISME J 2011, 5:665-673. 10.1038/ismej.2010.156, 3105741, 20962880.
66. Helling RB, Vargas CN, Adams J. Evolution of Escherichia coli during growth in a constant environment. Genetics 1987, 116:349-358. 1203146, 3301527.
67. Le Gac M, Plucain J, Hindre T, Lenski RE, Schneider D. Ecological and evolutionary dynamics of coexisting lineages during a long-term experiment with Escherichia coli. Proc Natl Acad Sci U S A 2012, 109:9487-9492. 10.1073/pnas.1207091109, 3386082, 22645336.
68. Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, Brown R, Hugenholtz P, DeSantis TZ, Andersen GL, Wiener-Kronish JP, Bristow J. Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 2007, 45:1954-1962. 10.1128/JCM.02187-06, 1933106, 17409203.
69. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
70. McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep 2012, 13:528-538. 10.1038/embor.2012.61, 3367245, 22595889.
71. Lee A, Endesfelder D, Rowan A, Walther A, Birkbak N, Futreal AP, Downward J, Szallasi Z, Tomlinson I, Kschischo M, Swanton C. Chromosomal instability confers intrinsic multi-drug resistance. Cancer Res 2011, 71:1858-1870. 10.1158/0008-5472.CAN-10-3604, 3059493, 21363922.
72. Birkbak NJ, Eklund AC, Li Q, McClelland SE, Endesfelder D, Tan P, Tan IB, Richardson AL, Szallasi Z, Swanton C. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res 2011, 71:3447-3452. 10.1158/0008-5472.CAN-10-3667, 3096721,3096721, 21270108.
73. Glickman MS, Sawyers CL. Converting cancer therapies into cures: lessons from infectious diseases. Cell 2012, 148:1089-1098. 10.1016/j.cell.2012.02.015, 3465702, 22424221.
74. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 2006, 127:905-915. 10.1016/j.cell.2006.09.042, 17129778.
75. Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011, 11:450-457. 10.1038/nrc3063, 21593786.
76. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MD, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339. 10.1038/nature12634, 24132290.
77. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, Larson DE, McLellan MD, Dooling D, Abbott R, Abbott R, Fulton R, Magrini V, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Fan X, Grillot M, Witowski S, Heath S, Frater JL, Eades W, Tomasson M, Westervelt P, DiPersio JF, Link DC, Mardis ER, Ley TJ, Wilson RK, Graubert TA. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012, 366:1090-1098. 10.1056/NEJMoa1106968, 3320218, 22417201.
78. Barrett RD, Schluter D. Adaptation from standing genetic variation. Trends Ecol Evol 2008, 23:38-44. 10.1016/j.tree.2007.09.008, 18006185.
79. Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, Akhavanfard S, Heist RS, Temel J, Christensen JG, Wain JC, Lynch TJ, Vernovsky K, Mark EJ, Lanuti M, Iafrate AJ, Mino-Kenudson M, Engelman JA. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011, 3:75ra26. 10.1126/scitranslmed.3002003, 3132801, 21430269.
80. Chmielecki J, Foo J, Oxnard GR, Hutchinson K, Ohashi K, Somwar R, Wang L, Amato KR, Arcila M, Sos ML, Socci ND, Viale A, de Stanchina E, Ginsberg MS, Thomas RK, Kris MG, Inoue A, Ladanyi M, Miller VA, Michor F, Pao W. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med 2011, 3:90ra59. 10.1126/scitranslmed.3002356, 3500629, 21734175.
81. Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese DJ, Settleman J, Haber DA. Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation. Cancer Res 2007, 67:7319-7326. 10.1158/0008-5472.CAN-06-4625, 2882853, 17671201.
82. Vikis H, Sato M, James M, Wang D, Wang Y, Wang M, Jia D, Liu Y, Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Yang P, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, Rothschild H, Mandal D, Kupert E, Seminara D, Viswanathan A, Govindan R, Minna J, Anderson MW, You M. EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 2007, 67:4665-4670. 10.1158/0008-5472.CAN-07-0217, 3460269, 17510392.
83. Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A 2008, 105:2070-2075. 10.1073/pnas.0709662105, 2538882, 18227510.
84. Gatenby RA, Silva AS, Gillies RJ, Frieden BR. Adaptive therapy. Cancer Res 2009, 69:4894-4903. 10.1158/0008-5472.CAN-08-3658, 3728826, 19487300.
85. Silva AS, Kam Y, Khin ZP, Minton SE, Gillies RJ, Gatenby RA. Evolutionary approaches to prolong progression-free survival in breast cancer. Cancer Res 2012, 72:6362-6370. 10.1158/0008-5472.CAN-12-2235, 23066036.
86. Taylor TB, Johnson LJ, Jackson RW, Brockhurst MA, Dash PR. First steps in experimental cancer evolution. Evol Appl 2013, 6:535-548. 10.1111/eva.12041, 3673480, 23745144.
87. Yap T, Gerlinger M, Futreal A, Pustzai L, Swanton C. Intratumour heterogeneity: seeing the wood for the trees. Sci Transl Med 2012, 4:127. ps10.
88. Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, Brenton JD, Caldas C, Rosenfeld N. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013, 497:108-112. 10.1038/nature12065, 23563269.